Ofatumumab is now listed in the interaction checker as a cancer drug and interactions can be found for all the comedications.
Ofatumumab (Arzerra®) is a monoclonal antibody and is indicated for the treatment of chronic lymphocytic B-cell leukemia.
Interaction Checker
This website was last updated on 1st June 2022 and interactions and content may have changed.
Tuesday 20 March 2018
Ofatumumab is now listed in the interaction checker as a cancer drug and interactions can be found for all the comedications.
Ofatumumab (Arzerra®) is a monoclonal antibody and is indicated for the treatment of chronic lymphocytic B-cell leukemia.